UBC Faculty Research and Publications

Statin’s benefit for secondary prevention confirmed : What is the optimal dosing strategy? Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 49 discusses optimal dosing strategies for statins for secondary prevention. Conclusions: Statins provide a cardiovascular and total mortality benefit for patients with clinically evident occlusive vascular disease (secondary prevention) and a cholesterol of >3.5 mM. Large RCTs are required to test different statin dosing strategies for secondary prevention before making firm recommendations.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International